Literature DB >> 19996094

Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6.

Shu Li1, Hao Zheng, Ai-Ping Mao, Bo Zhong, Ying Li, Yu Liu, Yan Gao, Yong Ran, Po Tien, Hong-Bing Shu.   

Abstract

Ubiquitination and deubiquitination have emerged as critical post-translational regulatory mechanisms for activation or attenuation of the virus-triggered type I interferon (IFN)(2) induction pathways. In this study, we identified two deubiquitinating enzymes, OTUB1 and OTUB2, as negative regulators of virus-triggered type I IFN induction. Overexpression of OTUB1 and OTUB2 inhibited virus-induced activation of IRF3 and NF-kappaB, transcription of the IFNB1 gene as well as cellular antiviral response, whereas knockdown of OTUB1 and OTUB2 had opposite effects. Coimmunoprecipitations indicated OTUB1 and -2 interacted with TRAF3 and TRAF6, two E3 ubiquitin ligases required for virus-triggered IRF3 and NF-kappaB activation, respectively. Furthermore, we found that OTUB1 and OTUB2 mediated virus-triggered deubiquitination of TRAF3 and -6. These findings suggest that OTUB1 and OTUB2 negatively regulate virus-triggered type I IFN induction and cellular antiviral response by deubiquitinating TRAF3 and -6.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996094      PMCID: PMC2836033          DOI: 10.1074/jbc.M109.074971

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Structure and function of the interferon-beta enhanceosome.

Authors:  T Maniatis; J V Falvo; T H Kim; T K Kim; C H Lin; B S Parekh; M G Wathelet
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1998

2.  Type I IFN modulates innate and specific antiviral immunity.

Authors:  J E Durbin; A Fernandez-Sesma; C K Lee; T D Rao; A B Frey; T M Moran; S Vukmanovic; A García-Sastre; D E Levy
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

3.  Otubains: a new family of cysteine proteases in the ubiquitin pathway.

Authors:  Maxim Y Balakirev; Sergey O Tcherniuk; Michel Jaquinod; Jadwiga Chroboczek
Journal:  EMBO Rep       Date:  2003-05       Impact factor: 8.807

4.  A20 is a negative regulator of IFN regulatory factor 3 signaling.

Authors:  Tatsuya Saitoh; Masahiro Yamamoto; Makoto Miyagishi; Kazunari Taira; Makoto Nakanishi; Takashi Fujita; Shizuo Akira; Naoki Yamamoto; Shoji Yamaoka
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 5.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

6.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

7.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.

Authors:  J Andrejeva; K S Childs; D F Young; T S Carlos; N Stock; S Goodbourn; R E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

8.  A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.

Authors:  Yan-Yi Wang; Lianyun Li; Ke-Jun Han; Zhonghe Zhai; Hong-Bing Shu
Journal:  FEBS Lett       Date:  2004-10-08       Impact factor: 4.124

9.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

10.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Authors:  Lijun Sun; Li Deng; Chee-Kwee Ea; Zong-Ping Xia; Zhijian J Chen
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

View more
  92 in total

1.  Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling.

Authors:  Puck B van Kasteren; Corrine Beugeling; Dennis K Ninaber; Natalia Frias-Staheli; Sander van Boheemen; Adolfo García-Sastre; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.

Authors:  Yuhuang Li; Xiao-Xin Sun; Johannes Elferich; Ujwal Shinde; Larry L David; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

4.  Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization.

Authors:  Yanchuan Li; Jin-Young Yang; Xiaoping Xie; Zuliang Jie; Lingyun Zhang; Jianhong Shi; Daniel Lin; Meidi Gu; Xiaofei Zhou; Haiyan S Li; Stephanie S Watowich; Antrix Jain; Sung Yun Jung; Jun Qin; Xuhong Cheng; Shao-Cong Sun
Journal:  Cell Res       Date:  2019-05-13       Impact factor: 25.617

5.  Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.

Authors:  Puck B van Kasteren; Ben A Bailey-Elkin; Terrence W James; Dennis K Ninaber; Corrine Beugeling; Mazdak Khajehpour; Eric J Snijder; Brian L Mark; Marjolein Kikkert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Authors:  Johanna Bialas; Annika N Boehm; Nicola Catone; Annette Aichem; Marcus Groettrup
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

7.  The kinase CK1ɛ controls the antiviral immune response by phosphorylating the signaling adaptor TRAF3.

Authors:  Yilong Zhou; Chenxi He; Dapeng Yan; Feng Liu; Haipeng Liu; Jianxia Chen; Ting Cao; Mianyong Zuo; Peng Wang; Yan Ge; Haojie Lu; Qinghe Tong; Chengfeng Qin; Yongqiang Deng; Baoxue Ge
Journal:  Nat Immunol       Date:  2016-02-29       Impact factor: 25.606

8.  OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.

Authors:  Honghong Zhou; Yongshuo Liu; Rui Zhu; Fang Ding; Xiufeng Cao; Dongxin Lin; Zhihua Liu
Journal:  Oncogene       Date:  2018-03-21       Impact factor: 9.867

9.  OTUB1 modulates c-IAP1 stability to regulate signalling pathways.

Authors:  Tatiana Goncharov; Kyle Niessen; Maria Cristina de Almagro; Anita Izrael-Tomasevic; Anna V Fedorova; Eugene Varfolomeev; David Arnott; Kurt Deshayes; Donald S Kirkpatrick; Domagoj Vucic
Journal:  EMBO J       Date:  2013-03-22       Impact factor: 11.598

Review 10.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.